EMPLOYMENT AGREEMENTEmployment Agreement • December 4th, 2017 • China SXT Pharmaceuticals, Inc. • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of December 4, 2017 (the “Effective Date”), by and between China SXT Pharmaceuticals, Inc., incorporated under the laws of the British Virgin Islands (the “Company”), and Yao Shi, an individual (the “Chief Financial Officer (CFO)”). Except with respect to the direct employment of the CFO by the Company, the term “Company” as used herein with respect to all obligations of the CFO hereunder shall be deemed to include the Company and all of its subsidiaries and affiliated entities (collectively, the “Group”).
EMPLOYMENT AGREEMENTEmployment Agreement • December 4th, 2017 • China SXT Pharmaceuticals, Inc. • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of December 4, 2017 (the “Effective Date”), by and between China SXT Pharmaceuticals, Inc., incorporated under the laws of the British Virgin Islands (the “Company”), and Feng Zhou, an individual (the “Chief Executive Officer (CEO)”). Except with respect to the direct employment of the CEO by the Company, the term “Company” as used herein with respect to all obligations of the CEO hereunder shall be deemed to include the Company and all of its subsidiaries and affiliated entities (collectively, the “Group”).
EMPLOYMENT AGREEMENTEmployment Agreement • December 4th, 2017 • China SXT Pharmaceuticals, Inc. • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”), is entered into as of December 4, 2017 (the “Effective Date”), by and between China SXT Pharmaceuticals, Inc., incorporated under the laws of the British Virgin Islands (the “Company”), and Jing Zhen Deng, an individual (the “Significant Employee”). Except with respect to the direct employment of the Significant Employee by the Company, the term “Company” as used herein with respect to all obligations of the Significant Employee hereunder shall be deemed to include the Company and all of its subsidiaries and affiliated entities (collectively, the “Group”).
EQUITY INTEREST PLEDGE AGREEMENTEquity Interest Pledge Agreement • December 4th, 2017 • China SXT Pharmaceuticals, Inc.
This Equity Interest Pledge Agreement (this “Agreement”) has been executed by and among the following parties on October 13, 2017 in Taizhou, the People’s Republic of China (“China” or the “PRC”):
Sales ContractSales Contract • December 4th, 2017 • China SXT Pharmaceuticals, Inc.
EXCLUSIVE BUSINESS COOPERATION AGREEMENTExclusive Business Cooperation Agreement • December 4th, 2017 • China SXT Pharmaceuticals, Inc.
This Exclusive Business Cooperation Agreement (this “Agreement”) is made and entered into by and between the following parties on October 13, 2017 in Taizhou, the People’s Republic of China (“China” or the “PRC”) .
EXCLUSIVE OPTION AGREEMENTExclusive Option Agreement • December 4th, 2017 • China SXT Pharmaceuticals, Inc.
This Exclusive Option Agreement (this “Agreement”) is executed by and among the following Parties as of October 13, 2017 in Taizhou, the People’s Republic of China (“China” or the “PRC”):
Purchase ContractPurchase Contract • December 4th, 2017 • China SXT Pharmaceuticals, Inc.
